433. How Are Psychedelics and Other Part...

Stephen Dubner had an idea for a new project. So he drove to Connecticut and knocked on the door of the master. Dubner’s new TV talk show Better in Person launches July 14 on the Freakonomics YouTube channel. SOURCES: Dick Cavett, writer, former talk show host. RESOURCES: Eye on ... Show More

Dartmouth president Sian Beilock, a psychologist by training, made her name studying why people choke. Now she’s applying those insights to one of the most scrutinized jobs in America. No pressure! SOURCES: Sian Beilock, president of Dartmouth College. RESOURCES: "Growing share o ... Show More

It’s a hard time to run a university: public trust is low, political pressure is high, and finances are fragile. But Daniel Diermeier, who trained as a political scientist, has Vanderbilt humming. How? He says the key is choosing magnets over wedges. SOURCES: Daniel Diermeier, ch ... Show More

When psychedelics were first studied more than 50 years ago, researchers noticed that they were useful in helping people explore a greater sense of self. Now, after a half-century hiatus, scientists are studying psychedelics like MDMA, psilocybin, and ketamine as treatment for de ... Show More

When psychedelics were first studied more than 50 years ago, researchers noticed that they were useful in helping people explore a greater sense of self. Now, after a half-century hiatus, scientists are studying psychedelics like MDMA, psilocybin, and ketamine as treatment for de ... Show More

<p dir="ltr">Sam Harris speaks with Dr. Jennifer Mitchell and Dr. Sarah Abedi about recent developments in research on psychedelics. They discuss the history of this research and the war on drugs, recent setbacks in the FDA approval process, MDMA as a treatment for post-traumatic ... Show More

<p>Hallucinogenic drugs are currently illegal, but they were once commonly used in psychological treatment. In this episode, Josh and Chuck discuss the rise and fall of psychedelics in treating mood disorders -- and why they're starting to gain favor again.</p><p> </p> Learn more ... Show More

We’re in the midst of a psychedelic renaissance, where this once demonized class of drugs is now front and center receiving attention among entrepreneurs, investors, clinical trials and even patients. In this special conversation, TED Health’s Dr. Shoshana Ungerleider speaks with ... Show More

Mental health disorders touch rich and poor, young and old, in every country around the world. Hear three experts discuss the evidence for interventions, how to get help to the right people, and which problem, if solved, would help the most. Hosted on Acast. See acast.com/privacy ... Show More

<p>Although psychadelic drugs are largely recreational these days, scientists are looking into potential therapeutic uses -- especially in patients for whom nothing else works. Learn how psilocybin may fight depression in this episode of BrainStuff.</p><p> </p> Learn more about y ... Show More